| 引用本文:雷 蕾.稳心颗粒治疗冠心病室性期前收缩82例临床观察[J].世界中医药,2014,9(07):. |
|
| 稳心颗粒治疗冠心病室性期前收缩82例临床观察 |
| Clinical Observation on Efficacy of Wenxin Granule to Treat Ventricular Contraction of Coronary Heart Disease in 82 Patients |
| 投稿时间：2014-01-26 |
| DOI：10.3969/j.issn.1673-7202.2014.07.011 |
| 中文关键词: 稳心颗粒 冠心病 期前收缩 室性 |
| English Keywords:Wenxin Granule Coronary Heart Disease Ventricular Contraction Ventricular |
| 基金项目: |
|
| 摘要点击次数: 1228 |
| 全文下载次数: 1476 |
| 中文摘要: |
| 目的：观察稳心颗粒治疗冠心病室性期前收缩的疗效和安全性。方法：对符合入选标准的冠心病室性期前收缩患者，采用自身对照、开放单一治疗试验设计方案，给予稳心颗粒9 g，3次/d，温开水冲服，连续服药8周，观察疗效和安全性。结果：24 h动态心电图室性期前收缩次数由入选时的(6 858±734)次减少至8周时的(2 640±438)次，减少幅度61.5%。显效率31.3%；有效率51.3%；无效率16.5%；总有效率83.5%。结论：稳心颗粒对冠心病室性期前收缩具有确切的抗心律失常的作用，依从性好，安全可靠。 |
| English Summary: |
| To observe curative effect and safety of Wenxin Granule to treat ventricular contraction of coronary heart disease. Methods： In a self-control， open monotherapy trial， patients were given 9 g Wenxin Granule， 3 times a day， for 8 weeks. Results： The occurrence of ventricular contraction observed in 24 h dynamic ECG was decreased from (6 858±734) before treatment to (2 640±438) after 8-week treatment， ie. decreased by 61.5%. Significant effective rate was 31.3%， effective rate was 51.3%， ineffective rate was 16.5%， total effective rate was 83.5%. Conclusion： Wenxin Granule is a safe medicure to treat ventricular contraction of coronary heart disease. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
